An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta‐analysis of time‐to‐event outcomes
- 12 September 2005
- journal article
- research article
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 11 (5) , 468-478
- https://doi.org/10.1111/j.1365-2753.2005.00559.x
Abstract
Combining the results of individual studies using meta-analysis may be undertaken using either aggregate data (AD) or individual patient data (IPD). In any meta-analysis it is important to consider statistical heterogeneity between studies. Potential sources of heterogeneity can be explored using regression models with either AD or IPD. An overview of approaches and empirical assessment of how the results and conclusions differ from these analyses is undertaken using a meta-analysis of five randomized controlled trials comparing two antiepileptic drugs with time-to-event outcomes. Alternative meta-regression models using AD are compared to stratified Cox regression models using IPD. Age as a potential cause of heterogeneity is detected by both AD and IPD regression models. Time from first ever seizure to randomization is only identified by some AD models. A more thorough explanation of heterogeneity is obtained from the model using IPD but further empirical evidence comparing IPD and AD results are needed.Keywords
This publication has 17 references indexed in Scilit:
- Aggregate data meta‐analysis with time‐to‐event outcomesStatistics in Medicine, 2002
- Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trialsStatistics in Medicine, 2002
- Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly headStatistics in Medicine, 2002
- The Value of the Aggregate Data Approach in Meta-Analysis with Time-to-Event OutcomesJournal of the Royal Statistical Society Series A: Statistics in Society, 2001
- Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsyThe Lancet, 1996
- Practical methodology of meta‐analyses (overviews) using updated individual patient dataStatistics in Medicine, 1995
- A MULTICENTRE COMPARATIVE TRIAL OF SODIUM VALPROATE AND CARBAMAZEPINE IN PAEDIATRIC EPILEPSYDevelopmental Medicine and Child Neurology, 1995
- Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health CareAnnals of the New York Academy of Sciences, 1993